Another retrospective cohort study derived from the Corporate Data Warehouse of the Veterans Health Administration covering 28,208 samples with at least a 7‐year follow‐up demonstrated that the risk of progression to cirrhosis in the steatosis group with normal ALT levels was much lower than that in the group with both steatosis and abnormal ALT levels but was not different from the risk among those without steatosis or elevated ALT [35]. This evidence concerns the gene GPT and Cirrhosis.